FindTrial
Sign In

Analysis of the correlation between immune-inflammatory indicators and sarcopenia in patients with liver cirrhosis

Analysis of the correlation between immune-inflammatory indicators and sarcopenia in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101245
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, sarcopenia

Interventions

Sarcopenia group:None
non-sarcopenia group:None

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosed with liver cirrhosis; 2.Age >= 45 years old; 3.Able to cooperate in completing relevant indicator testing; 4.Voluntarily sign the relevant research informed consent form.

Exclusion criteria

Exclusion criteria: 1.Combined with other diseases that affect muscle or immune status (such as malignant tumors, renal failure, recent surgery); 2.Receiving drug treatment that affects metabolism or immunity (such as long-term glucocorticoid treatment); 3.Those with serious complications and unstable vital signs; 4.People with pacemakers and metal implants; 5.Those who are unable to cooperate due to mental illness or disability; 6.Those with incomplete case information.

Design outcomes

Primary

MeasureTime frame
Grip strength;SMI;6-meter pace test;Immunity-Inflammation Index ;—

Countries

China

Contacts

Public ContactLiu Huanbing

The first affiliated hostipal of nanchang university

liuhuanbing6911@sina.com+86 791 8869461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026